Similarly, Morioka et al., found that F4 enhances the cytotoxicity of human peripheral blood lymphocytes against tumor cells, especially when F4 is used in combination with a suboptimal dosage of IL-2 or Con-A [121]. This evidence concerns the gene IL2 and neoplasm.